The type, size and duration of vaccination zones I and II set out in Parts B and A of Annex II to Implementing Decision (EU) 2025/2248 need to be amended in the light of the evolving epidemiological situation in Spain as regards infection with lumpy skin disease virus, and the progress of the vaccination campaign, particularly taking into account the evolving level of vaccine coverage achieved. Accordingly, it is necessary to indicate, in Annex II to that Implementing Decision, the dates for the duration of the vaccination zones I and II.
Recital 8, Decision_act (EU) 2026/552
In forcesince 6 Mar 2026